Outline and computational approaches of protein misfolding

Abstract

Protein misfolding is a general causation of classical conformational diseases and many pathogenic changes that are the result of structural conversion. Here I review recent progress in clinical and computational approaches for each stage of the misfolding process, aiming to present readers an outline for swift comprehension of this field.

Key words： computational approaches; protein misfolding; conformational diseases

References

1 Abrahamson M (1996). Molecular basis for amyloidosis related to hereditary brain hemorrhage. Scand J Clin Lab Invest, 226: 47–56

2 Bemporad F, Calloni G, Campioni S, Plakoutsi G, Taddei N, Chiti F (2006). Sequence and structural determinants of amyloid fibril formation. Acc Chem Res, 39: 620–627

3 Bitan G, Vollers S S, Teplow D B (2003). Elucidation of primary structure elements controlling early amyloid-beta protein oligomerisation. J Biol Chem, 278: 34882–34889

4 Bonvin A M (2006). Flexible protein-protein docking. Curr Opin Struct Biol, 16: 194–200

5 Bornholdt Z A, Prasad B V V (2008). X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature, 456: 985–988

6 Brändén C I, Tooze J (1999). Introduction to protein structure. 2nd ed. New York: Garland Publishing

7 Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002). Inherent cytotoxicity of aggregates implies a common origin for protein misfolding diseases. Nature, 416: 507–511

8 Caflisch A (2006). Computational models for the prediction of polypeptide aggregation propensity. Curr Opin Chem Biol, 10: 437–444

9 Capaldi A P, Kleanthous C, Radford S E (2002). Im7 folding mechanism: misfolding on a path to the native state. Nat Struct Biol, 9: 209–216

10 Carrell R W, Gooptu B (1998). Conformational changes and diseases-serpins, prions, and Alzheimer's. Curr Opin Struct Biol, 8: 799–809

11 Carrell R W, Lomas D A (1997). Conformational disease. Lancet, 350: 134–138

12 Castillo V, Ventura S (2009). Amyloidogenic Regions and Interaction Surfaces Overlap in Globular Proteins Related to Conformational Diseases. PLoS Comput Biol, 5: e1000476

13 Caughey B, Lansbury P T (2003). Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci, 26: 267–298

14 Chiti F, Taddei N, Baroni F, Capanni C, Stefani M, Ramponi G, Dobson C M (2002). Kinetic partitioning of protein folding and aggregation. Nat Struct Biol, 9:137–143

15 Davis R, Dobson C M, Vendruscolo M (2002). Determination of the structures of distinct transition state ensembles for a β-sheet peptide with parallel folding pathways. J Chem Phys, 117: 9510–9517

16 DeMarco M L, Daggett V (2004). From conversion to aggregation: Protofibril formation of the prion protein. Proc Natl Acad Sci USA, 101:2293–2298

17 Dill K A, Chan H S (1997). From Levinthal to pathways to funnels. Nat Struct Biol, 4: 10–19

18 Dinner A R, Sali A, Smith L J, Dobson C M, Karplus M (2000). Understanding protein folding via free energy surfaces from theory and experiment. Trends Biochem Sci, 25: 331–339

19 Dobson C M (1999). Protein misfolding, evolution and disease. Trends Biochem Sci, 24: 329–332

20 Dobson C M (2002). Getting out of shape-protein misfolding diseases. Nature, 418: 729–730

21 Dobson C M (2003). Protein folding and disease: a view from the first Horizon symposium. Nat Rev Drug Discov, 2: 154–160

22 Dobson C M (2004). Principles of protein folding, misfolding and aggregation. Semin Cell Dev Bio, 15: 3–16

23 Dobson C M, Sali A, Karplus M (1998). Protein folding: a perspective from theory and experiment. Angew Chem Int Ed Eng, 37: 868–893

24 Fernandez-Escamilla A M, Rousseau F, Schymkowitz J, Serrano L (2004). Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol, 22: 1302–1306

25 Fersht A (1999). Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding. New York: WH Freeman

26 Fersht A R (2000). Transition-state structure as a unifying basis in protein-folding mechanisms: contact order, chain topology, stability, and the extended nucleus mechanism. Proc Natl Acad Sci USA, 97:1525–1529

27 Galzitskaya O V, Garbuzynskiy S O, Lobanov M Y (2006). Is it possible to predict amyloidogenic regions from sequence alone? J Bioinform Comput Biol, 4: 373–388

28 Garten R J, Davis C T, Russell C A, Shu B, Lindstrom S, Balish A, Sessions W M, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith C B, Emery S L, Hillman M J, Rivailler P, Smagala J, de Graaf M, Burke D F, Fouchier R A, Pappas C, Alpuche-Aranda C M, López-Gatell H, Olivera H, López I, Myers C A, Faix D, Blair P J, Yu C, Keene K M, Dotson P D Jr, Boxrud D, Sambol A R, Abid S H, St George K, Bannerman T, Moore A L, Stringer D J, Blevins P, Demmler-Harrison G J, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara H F, Belongia E A, Clark P A, Beatrice S T, Donis R, Katz J, Finelli L, Bridges C B, Shaw M, Jernigan D B, Uyeki T M, Smith D J, Klimov A I, Cox N J (2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 325: 197–201

29 Gething M J, Sambrook J (1992). Protein folding in the cell. Nature, 355: 33–45

30 Govaerts C, Wille H, Prusiner S B, Cohen F E (2004). Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci USA, 101: 8342–8347

31 Gray J J (2006). High-resolution protein-protein docking. Curr Opin Struct Biol, 16: 183–193

32 Hardesty B, Kramer G (2001). Folding of a nascent peptide on the ribosome. Prog Nucleic Acid Res Mol Biol, 66:41–66

33 Hardy J, Cai H, Cookson M R, Gwinn-Hardy K, Singleton A (2006). Genetics of Parkinson's disease and parkinsonism. Ann Neurol, 60: 389–398

34 Hardy J, Selkoe D J (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297: 353–356

35 Hartl F U, Hayer-Hartl M (2002). Molecular chaperones in the cytosol: from nascent chain to folded protein. Science, 295: 1852–1858

36 Hore P J, Winder S L, Roberts C H, Dobson C M (1997). Stopped-flow photo-CIDNP observation of protein folding. J Am Chem Soc, 119: 5049–5050

37 Höppener J W, Nieuwenhuis M G, Vroom T M, Ahrén B, Lips C J (2002). Role of islet amyloid in type 2 diabetes mellitus: consequence or cause? Mol Cell Endocrinol, 197: 205–212

38 Huang Z W, Prusiner S B, Cohen F E (1996). Scrapie prions: a three-dimensional model of an infectious fragment. Fold Des, 1: 13–19

39 Ivanova M I, Sawaya M R, Gingery M, Attinger A, Eisenberg D (2004). An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA, 101: 10584–10589

40 Karplus M (1997). The Levinthal paradox, yesterday and today. Fold Des, 2: S69–S76

41 Kelly J W (1996). Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol, 6: 11–17

42 Koo E H, Lansbury P T Jr, Kelly J W (1999). Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci USA, 96: 9989–9990

43 Kuwata K, Nishida N, Matsumoto T, Kamatari Y O, Hosokawa-Muto J, Kodama K, Nakamura H K, Kimura K, Kawasaki M, Takakura Y, Shirabe S, Takata J, Kataoka Y, Katamine S (2007). Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci USA, 104: 11921–11926

44 Liu X, Zhao Y P (2009a). A scheme for multiple sequence alignment optimization-- an improvement based on family representative mechanics features. J Theor Biol, 261: 593–597

45 Liu X, Zhao Y P (2009b). Donut-shaped fingerprint in homologous polypeptide relationships--a topological feature related to pathogenic structural conversion of conformational disease. J Theor Biol, 258: 294–301

46 Liu X, Zhao Y P (2010a). Generating artificial homologous proteins according to the representative family characteristic in molecular mechanics properties. FEBS Lett, (in press)

47 Liu X, Zhao Y P (2010b). Simulated pathogenic conformational switch regions matched well with the biochemical findings. J Biomed Inform, (in press)

48 Liu X, Zhao Y P (2010c). Switch region for pathogenic structural change in conformational disease and its prediction. Plos One, 5(1): e8441

49 López de la Paz M, Goldie K, Zurdo J, Lacroix E, Dobson C M, Hoenger A, Serrano L (2002). De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci USA, 99: 16052–16057

50 López de la Paz M, Serrano L (2004). Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA, 101: 87–92

51 Makarov D E, Plaxco K W (2003). The topomer search model: a simple, quantitative theory of two-state protein folding kinetics. Protein Sci, 12: 17–26

52 Mastrangelo I, Ahmed M, Sato T, Liu W, Wang C, Hough P, Smith S O (2006). High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol, 358: 106–109

53 Matouschek A, Kellis J T, Serrano L, Fersht A R (1989). Mapping the transition state and pathway of protein folding by protein engineering. Nature, 342: 122–126

54 Meiering E M (2008). The threat of instability: neurodegeneration predicted by protein destabilization and aggregation propensity. Plos Biol, 6: e193

55 Nelson R, Sawaya M R, Balbirnie M, Madsen A Ø, Riekel C, Grothe R, Eisenberg D (2005). Structure of the cross-beta spine of amyloid-like fibrils. Nature, 435: 773–778

56 Ólafsson Í, Grubb A (2000). Hereditary cystatin C amyloid angiopathy. Amyloid, 7: 70–79

57 Pawar A P, Dubay K F, Zurdo J, Chiti F, Vendruscolo M, Dobson C M (2005). Prediction of “aggregation-prone” and “aggregation-susceptible” regions in proteins associated with neurodegenerative diseases. J Mol Biol, 350: 379–392

58 Pepys M B (1995). The Oxford textbook of medicine. 3rd ed. Oxford: Oxford University Press, 1512–1524

59 Polverino de Laureto P, Taddei N, Frare E, Capanni C, Costantini S, Zurdo J, Chiti F, Dobson C M, Fontana A (2003). Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J Mol Biol, 334: 129–141

60 Prusiner S B (1997). Prion diseases and the BSE crisis. Science, 278: 245–251

61 Saiki M, Konakahara T, Morii H (2006). Interaction-based evaluation of the propensity for amyloid formation with cross-beta structure. Biochem Biophys Res Commun, 343: 1262–1271

63 Sánchez de Groot N, Pallarés I, Avilés FX, Vendrell J, Ventura S (2005). Prediction of “hot spots” of aggregation in disease-linked polypeptides. BMC Struct Biol, 5: 18

64 Sawaya M R, Sambashivan S, Nelson R, Ivanova M I, Sievers S A, Apostol M I, Thompson MJ, Balbirnie M, Wiltzius J J, McFarlane H T, Madsen A Ø, Riekel C, Eisenberg D (2007). Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature, 447(7143): 453–457

65 Smirnovas V, Kim J I, Lu X, Atarashi R, Caughey B, Surewicz W K (2009). Distinct structures of Scrapie Prion Protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. J Biol Chem, 284(36): 24233–24241

66 Soto C (2001). Protein misfolding and disease; protein refolding and therapy. FEBS lett, 498: 204–207

67 Stefani M, Dobson C M (2003). Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med, 81: 678–699

68 Thomas P J, Qu B H, Pedersen P L (1995). Defective protein folding as a basis of human disease. Trends Biochem Sci, 20: 456–459

69 Walsh D M, Klyubin I, Fadeeva J V, Cullen W K, Anwyl R, Wolfe M S, Rowan M J, Selkoe D J (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416: 535–539

70 Wei G, Mousseau N, Derreumaux P (2007). Computational simulations of the early steps of pProtein aggregation. Prion, 1: 3–8

71 Wolynes P G, Onuchic J N, Thirumalai D (1995). Navigating the folding routes. Science, 267: 1619–1623

72 Vendruscolo M, Paci E, Dobson C M, Karplus M (2001). Three key residues form a critical contact network in a transition state for protein folding. Nature, 409: 641–645

73 Ventura S, Zurdo J, Narayanan S, Parreño M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson C M, Aviles F X, Serrano L (2004). Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA, 101: 7258–7263

74 Yoon S, Welsh W J (2004). Detecting hidden sequence propensity for amyloid fibril formation. Protein Sci, 13: 2149–2160

75 Zhang Z, Chen H, Lai L (2007). Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics, 23: 2218–2225